Ajanta Pharma posts 11.60 percent rise in net profit at Rs 105.79 crore in Q1
"We are pleased with our June quarter performance which is in line with our expectations. Branded generic business in India and Export markets posted healthy growths," MD Yogesh Agrawal said.
The company had posted a net profit of Rs 94.79 crore in the year-ago period, Ajanta Pharma said in a BSE filing. Consolidated income from operations stood at Rs 510.99 crore for the reported quarter. It was Rs 473.12 crore for the same period a year ago.
Despite challenging pricing environment in the US, the company has posted healthy growth for the quarter, he added.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)